AKT1 and neuroblastoma: e. the role of sequential scheduling of inducer and sensitizers, we used several inhibitors of the PI3K/Akt network, such as the pan-specific PI3K-inhibitor NVP-BEZ235, in combination with doxorubicin, a drug frequently used in NB treatment [15].